Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

Go back to Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
(NASDAQ: QNRX) Delayed: 3.25 -1.16 (26.3%)
Previous Close $4.41    52 Week High
Open $4.20    52 Week Low
Day High $5.07    P/E N/A 
Day Low $3.25    EPS
Volume 3,346,300